posts tagged as Pharmaceuticals
Healthcare Reform: Insights from Inside the Beltway
We recently hosted a breakfast panel, Healthcare Reform: Insights from Inside the Beltway, during the 2017 J.P. Morgan Healthcare Conference, featuring our senior fellow, Dr. Scott Gottlieb, and Dave Tamasi of Rasky Baerlein, along with...
2 Compliance Takeaways from the 21st Century Cures Act
On Dec. 13, President Obama signed the 21st Century Cures Act (the Cures Act) into law, boosting healthcare research dollars, streamlining the Food and Drug Administration (FDA)’s drug and medical device approvals processes, and...
BDO Knows Healthcare Spring 2016 Newsletter
In the Spring 2016 edition of the BDO Knows Healthcare newsletter, we focus on the impact of changing reimbursements across the healthcare spectrum: on investors, providers and pharmaceutical companies.